OncoPharm cover image

Clinical Trial Endpoints in Oncology

OncoPharm

00:00

Response Rate and Special Considerations

John Bazar explains objective response rate as activity evidence and discusses transplant, CAR-T, and CINV endpoint examples.

Play episode from 10:40
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app